JAN 15, 2016 11:46 AM PST

Inflammation, Glutamate, and Treating Depression

WRITTEN BY: Kara Marker
While inflammation triggered by the immune system is a vital response in many cases like when pathogens invade the body, inflammation at the wrong time or too much inflammation can cause problems. Inflammation has even been identified as a potential cause of depression, and scientists from the Emory School of Medicine recently showed locating these inflammatory markers in the brain could lead them to new drug targets for certain cases of depression.
 
Elevated glutamate levels in the basal ganglia, an area of the brain devoted to motor control, motivation, and decision making, was found to be associated with depressed patients who also have systemic inflammation (Neuroscience Online). Based on this association, Emory researchers aimed to identify which depression patients would respond best to medication targeting high levels of glutamate in their new study published in Molecular Psychiatry.
 
Glutamate is the “major excitatory transmitter” in the brain, but at too-high levels it can be toxic to neurons and glia, which are needed for healthy brain function (The Neurotransporter Group). This particular study focused on glutamate levels in the basal ganglia after previous studies discovered that hepatitis C treatments stimulated inflammation, depressive symptoms, and increased glutamate in the basal ganglia.
 
“Inflammation markers can guide us to which depressed patients respond best to glutamate blockers," lead author Ebrahim Haroon, MD, said about the study. "This could be an important step toward personalizing treatment for depression."
 
Glutamate and depression

Haroon and his team looked at 50 patients with depression not currently receiving antidepressant treatment. They looked for C-reactive protein (CRP) prevalence in the blood stream, a marker of inflammation since protein levels, produced by the liver, rise when there is inflammation in the body (MedlinePlus). They also measured glutamate levels in the basal ganglia using magnetic resonance spectroscopy (MRS) and myo-inositol, a marker for glial health.
 
Indeed, their results showed slow motor function, measured by finger tapping speed, and anhedonia, the inability to feel pleasure and a common characteristic of depression, coincided with high levels of glutamate and myo-inositol in the basal ganglia.
 
This study provides new insight into how individualizing depression treatments can make controlling and limiting the disease much easier. The next challenge for researchers devoted to the connection between inflammation, glutamate, and depression will be to reduce depression-causing inflammation without dampening the power of the immune system to fight disease.
 
For more on treating depression in patients with high levels of glutamate, check out the following video.
 
 
 
Source: Emory Health Sciences
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 05, 2020
Microbiology
Deadly Microbe Linked to Childhood Brain Disorder
OCT 05, 2020
Deadly Microbe Linked to Childhood Brain Disorder
Pediatric hydrocephalus - excessive fluid on the brain of a child - has been connected to a bacterial pathogen.
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
OCT 16, 2020
Drug Discovery & Development
FDA Warns Against NSAIDs After Week 20 of Pregnancy
OCT 16, 2020
FDA Warns Against NSAIDs After Week 20 of Pregnancy
The US Food and Drug Administration (FDA) has warned against using nonsteroidal anti-inflammatory drugs (NSAIDs) from 20 ...
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
OCT 18, 2020
Cell & Molecular Biology
Small RNA is Connected to Bacterial Pathogenicity
OCT 18, 2020
Small RNA is Connected to Bacterial Pathogenicity
It's thought that as much as half of the global population carries a bacterium called Helicobacter pylori in their stoma ...
OCT 22, 2020
Health & Medicine
OCD Symptoms Show Improvement With Cannabis Use
OCT 22, 2020
OCD Symptoms Show Improvement With Cannabis Use
Obsessive-compulsive order symptoms could be eased by cannabis according to a study published in the Journal of Affectiv ...
Loading Comments...